QCLS: the cash flow

MyFinsight

For the quarter ending 2025-09-30, QCLS had $6,731,031 increase in cash & cash equivalents over the period.

Cash Flow	2025-09-30
Change in fair value of warrants	0
Loss on issuance of series f-1 convertible preferred stock	0
Loss on issuance of series g convertible preferred stock	0
Operating leases	0
Deferred compensation payable	0
Net income/(loss)	-5,732,326
Gain on sale of marketable securities	2,176
Change in fair value of derivatives	244,000
Options issued to directors	110,168
Options issued to key employees	35,103
Options issued to non-employees	44,219
Prepaid expenses	256,561
Trade and other payables	178,261
Change in fair value of marketable securities	-1,435
Net cash used by operating activities	-5,865,877
Purchase of technology license	2,009,022
Purchases of marketable securities	5,955,495
Proceeds from sale of marketable securities	11,209,546
Net cash provided by/(used in) investing activities	3,245,029
Redemption of series f convertible preferred stock	0
Premium on series f convertible preferred stock	0
Dividends on preferred stock	0
Net proceeds from the issuance of series f-1 convertible preferred stock	0
Net proceeds from the issuance of series g convertible preferred stock	0
Net proceeds from the issuance of series h convertible preferred stock	6,654,838
Net proceeds from the exercise of warrants for common stock	2,697,041
Net cash provided by financing activities	9,351,879
Net increase/(decrease) in cash	6,731,031
Cash and cash equivalents at beginning of period	173,154
Cash and cash equivalents at end of period	6,904,185

Unit: Dollar. Numbers labeled with * are estimated quarterly values.